ISSN 1671-5411 CN 11-5329/R
Volume 20 Issue 5
May  2023
Turn off MathJax
Article Contents
Please cite this article as: Bellanti F, Amato R, Centola A, Ercolano V, Barbera L, Tesse A, Divittorio G, Capurso C, Lo Buglio A, Vendemiale G. From post-COVID-19-associated myocarditis to hemopericardium: a dangerous domino effect. J Geriatr Cardiol 2023; 20(5): 391−396. DOI: 10.26599/1671-5411.2023.05.008
Citation: Please cite this article as: Bellanti F, Amato R, Centola A, Ercolano V, Barbera L, Tesse A, Divittorio G, Capurso C, Lo Buglio A, Vendemiale G. From post-COVID-19-associated myocarditis to hemopericardium: a dangerous domino effect. J Geriatr Cardiol 2023; 20(5): 391−396. DOI: 10.26599/1671-5411.2023.05.008

From post-COVID-19-associated myocarditis to hemopericardium: a dangerous domino effect

doi: 10.26599/1671-5411.2023.05.008
More Information
  • loading
  • [1]
    Sah P, Fitzpatrick MC, Zimmer CF, et al. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proc Natl Acad Sci U S A 2021; 118: e2109229118. doi: 10.1073/pnas.2109229118
    Long B, Carius BM, Chavez S, et al. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. Am J Emerg Med 2022; 54: 46−57. doi: 10.1016/j.ajem.2022.01.028
    Schulze H, Charles JJ, Trampe N, et al. Cross-sectional analysis of clinical aspects in patients with long-COVID and post-COVID syndrome. Front Neurol 2022; 13: 979152. doi: 10.3389/fneur.2022.979152
    Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022; 22: e102−e107. doi: 10.1016/S1473-3099(21)00703-9
    Mohammad KO, Lin A, Rodriguez JBC. Cardiac manifestations of post-acute COVID-19 infection. Curr Cardiol Rep 2022; 24: 1775−1783. doi: 10.1007/s11886-022-01793-3
    Gaine S, Devitt P, Coughlan JJ, et al. COVID-19-associated myocarditis presenting as new-onset heart failure and atrial fibrillation. BMJ Case Rep 2021; 14: e244027. doi: 10.1136/bcr-2021-244027
    Zuin M, Rigatelli G, Bilato C, et al. One-Year Risk of Myocarditis After COVID-19 Infection: A Systematic Review and Meta-analysis. Can J Cardiol 2022. DOI: 10.1016/j.cjca.2022.12.003. Published online first: Dec 12, 2022.
    Hernandez I, Gabriel N, He M, et al. COVID-19 and anticoagulation for atrial fibrillation: an analysis of US nationwide pharmacy claims data. J Am Heart Assoc 2021; 10: e023235. doi: 10.1161/JAHA.121.023235
    Schiavone M, Sozzi FB, Gasperetti A, et al. Clinical management of new-onset atrial fibrillation in COVID-19 patients referred to a tertiary cardiac arrhythmia center after hospital discharge. J Clin Med 2022; 11: 5661. doi: 10.3390/jcm11195661
    Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation 2022; 145: 242−255. doi: 10.1161/CIRCULATIONAHA.121.056355
    Xu B, MacIsaac A. Life-threatening haemorrhagic pericarditis associated with rivaroxaban. Int J Cardiol 2014; 174: e75−e76. doi: 10.1016/j.ijcard.2014.04.151
    Rizzi DA, Pedersen SA. Causality in medicine: towards a theory and terminology. Theor Med 1992; 13: 233−254. doi: 10.1007/BF00489201
    Huseynov A, Akin I, Duerschmied D, et al. Cardiac Arrhythmias in post-COVID syndrome: prevalence, pathology, diagnosis, and treatment. Viruses 2023; 15: 389. doi: 10.3390/v15020389
    Liguori C, Farina D, Vaccher F, et al. Myocarditis: imaging up to date. Radiol Med 2020; 125: 1124−1134. doi: 10.1007/s11547-020-01279-8
    Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res 2021; 128: 1214−1236. doi: 10.1161/CIRCRESAHA.121.317997
    Lazzerini PE, Laghi-Pasini F, Boutjdir M, et al. Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19. Nat Rev Immunol 2022; 22: 270−272. doi: 10.1038/s41577-022-00714-3
    Fujinami RS, von Herrath MG, Christen U, et al. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006; 19: 80−94. doi: 10.1128/CMR.19.1.80-94.2006
    Marraki ZE, Bouzhir A, Nguadi J, et al. Post-COVID myocarditis simulating acute coronary syndrome: Case report. Radiol Case Rep 2023; 18: 665−670. doi: 10.1016/j.radcr.2022.11.023
    Baksi AJ, Kanaganayagam GS, Prasad SK. Arrhythmias in viral myocarditis and pericarditis. Card Electrophysiol Clin 2015; 7: 269−281. doi: 10.1016/j.ccep.2015.03.009
    Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int J Cardiol 2008; 127: 17−26. doi: 10.1016/j.ijcard.2007.10.053
    Raatikainen P, Lassila R. COVID-19: another reason for anticoagulation in patients with atrial fibrillation. Heart 2022; 108: 902−904. doi: 10.1136/heartjnl-2022-320845
    January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1−e76. doi: 10.1016/j.jacc.2014.03.022
    Julia S, James U. Direct Oral Anticoagulants: A Quick Guide. Eur Cardiol 2017; 12: 40−45. doi: 10.15420/ecr.2017:11:2
    Sheikh AB, Shah I, Sagheer S, et al. Hemopericardium in the Setting of Direct Oral Anticoagulant Use: An Updated Systematic Review. Cardiovasc Revasc Med 2022; 39: 73−83. doi: 10.1016/j.carrev.2021.09.010
    Asad ZUA, Ijaz SH, Chaudhary AMD, et al. Hemorrhagic cardiac tamponade associated with apixaban: a case report and systematic review of literature. Cardiovasc Revasc Med 2019; 20: 15−20. doi: 10.1016/j.carrev.2019.04.002
    Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239−245. doi: 10.1038/clpt.1981.154
    Fernandez S, Lenoir C, Samer C, et al. Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports. Pharmacol Res Perspect 2020; 8: e00647.
    Shah N, Saleh M, Jyala A, et al. COVID-19-Induced Myopericarditis Leading to Cardiac Tamponade: An Unusual Case Presentation. Cureus 2022; 14: e27158.
  • 加载中


    通讯作者: 陈斌,
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(1)

    Article Metrics

    Article views (154) PDF downloads(50) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint